John C. Rhee
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 16
- Colorectal Cancer Treatments and Studies 5
- Cancer Immunotherapy and Biomarkers 5
- Peptidase Inhibition and Analysis 4
- Lung Cancer Research Studies 2
-
- Protein Degradation and Inhibitors 2
- Cancer therapeutics and mechanisms 2
- Co-authors
- Dong M. Shin (3 shared papers)Fadlo R. Khuri (3 shared papers)William L. Smith (1 shared paper)Robert C. Osorio (1 shared paper)Jennifer Guy (1 shared paper)Maha Boktour (1 shared paper)Robert W. Osorio (1 shared paper)Catherine Frenette (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Cancer Chemotherapy and Pharmacology (2 papers)The Oncologist (2 papers)Expert Opinion on Emerging Drugs (2 papers)Clinical Epigenetics (1 paper)
- Partner nations
- United StatesPolandChina
In The Last Decade
John C. Rhee
21 papers receiving 233 citations
Peers
Comparison fields: 5 of 61
- Hepatology 44
- Oncology 98
- Immunology 43
- Otorhinolaryngology 8
- Cancer Research 26
Countries citing papers authored by John C. Rhee
This map shows the geographic impact of John C. Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Rhee more than expected).
Fields of papers citing papers by John C. Rhee
This network shows the impact of papers produced by John C. Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Rhee. The network helps show where John C. Rhee may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Rhee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 42 | |
| 2 | 2014 | 36 | |
| 3 | 1994 | 34 | |
| 4 | 2004 | 28 | |
| 5 | 2017 | 26 | |
| 6 | 2005 | 12 | |
| 7 | 2023 | 10 | |
| 8 | 2024 | 7 | |
| 9 | 2005 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2025 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2004 | 3 | |
| 15 | 2017 | 3 | |
| 16 | 2004 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2025 | 1 |
About John C. Rhee
John C. Rhee is a scholar working on Oncology, Molecular Biology, Hepatology, Surgery and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 235 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Peptidase Inhibition and Analysis (4 papers), Protein Degradation and Inhibitors (2 papers), Cancer therapeutics and mechanisms (2 papers), Lung Cancer Research Studies (2 papers) and Head and Neck Cancer Studies (2 papers). The work is most often cited by research in Hepatology (44 citations), Oncology (98 citations), Immunology (43 citations), Otorhinolaryngology (8 citations) and Cancer Research (26 citations). John C. Rhee has collaborated with scholars based in United States, Poland and China. Frequent co-authors include Dong M. Shin, Fadlo R. Khuri, William L. Smith, Robert C. Osorio, Jennifer Guy, Maha Boktour, Robert W. Osorio, Catherine Frenette, Edward Chu and Stanley M. Marks. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, The Oncologist, Expert Opinion on Emerging Drugs and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.